Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» GTx
GTx
Private oncology outfit Oncternal uses GTx as shell to make Nasdaq debut
Endpoints
Thu, 03/7/19 - 10:27 am
Oncternal
GTx
NASDAQ
oncology
GTx reports 1Q loss
Yahoo/AP
Fri, 05/8/15 - 09:03 am
earnings
GTx
GTx reports results from Phase 2 study of enobosarm
Yahoo/Fly on the Wall
Mon, 06/2/14 - 02:58 pm
GTx
enobosarm
breast cancer
metastatic breast cancer
ASCO
SEC cries insider trading in GTx's halted cancer trial
Fierce Pharma
Tue, 05/20/14 - 04:04 pm
SEC
GTx
Capesaris
GTx says current POWER trials data insufficient to support filing NDA
The Fly on the Wall
Thu, 05/8/14 - 11:23 am
GTx
enobosarm
non-small cell lung cancer
GTx: 4 Reasons Why This $1 Biotech Stock Could Be Poised For A Big Rebound
Seeking Alpha
Sat, 08/31/13 - 10:26 am
GTx
This Week in Biotech
Motley Fool
Sun, 08/25/13 - 11:27 am
Supernus Pharmaceuticals
Novartis
Pain Therapeutics
GTx
GTx says muscle drug fails in late-stage trials
Reuters
Mon, 08/19/13 - 09:48 am
GTx
enobosarm
cancer-induced muscle wasting
MannKind, Vical, GTx: Investors Predict Pivotal Clinical Trial Results
TheStreet.com
Mon, 08/5/13 - 07:23 am
MannKind
Vical
clinical trials
GTx
diabetes
Afrezza
melanoma
Allovectin-7
enobosarm
lung cancer-related muscle wasting
The Best- And Worst-Performing Biotech Stocks July 19 To July 26
Forbes
Mon, 07/29/13 - 12:27 pm
TearLab
Array Biopharma
Furiex Pharmaceuticals
InterMune
Prosensa
Boston Scientific
Orexigen
Momenta
Ironwood
INSYS Therapeutics
Sequenom
OncoMed
Abraxis
Sarepta
Epizyme
Tesaro
Synta Pharmaceuticals
Bluebird Bio
Exelixis
Lexicon Pharmaceuticals
Intercept Pharma
GTx
3 Biotech Catalysts Primed To Be Successful In Q3
Seeking Alpha
Wed, 07/24/13 - 09:48 am
BIOD-123
Biodel
MannKind
Afrezza
GTx
The Best- And Worst-Performing Biotech Stocks July 5 To July 12
Forbes
Mon, 07/15/13 - 11:58 am
Vivus
Trius Therapeutics
Prosensa
Pharmacyclics
NxStage Medical
Natus Medical
MiMedx
Merrimack Pharmaceuticals
Intuitive Surgical
InterMune
GTx
Fluidigm
Epizyme
Celldex
Astex
Analogic
Amarin
Alnylam
Alexion
AcelRx
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sat, 07/13/13 - 12:02 pm
Merrimack Pharmaceuticals
GTx
Intuitive Surgical
GTX Incorporated: Its 'Other' Drug, Capesaris
Seeking Alpha
Sat, 07/6/13 - 11:52 am
GTx
Capesaris
prostate cancer
Biotech Stock Mailbag: 2013 Clinical Trials Calendar
TheStreet.com
Fri, 06/7/13 - 08:41 am
Zerenex
Xoma
Vical
Takeda
sovaprevir
Soluble Ferric Pyrophosphate
Rockwell Medical
Orexigen
MM-398
Merrimack Pharmaceuticals
MannKind
Keryx
GTx
GSK
gevokizumab
enobosarm
Coronado Biosciences
Contrave
CNDO-201
clinical trials
ChemoCentryx
CCX140
Biodel
BIOD-123
Amigal
Amicus Therapeutics
Alnylam
ALN-TTR02
Allovectin
Afrezza
Achillion
ACH-3102
PSivida Corporation And GTx: 2 Of The Most Undervalued Biotechs For 2013
Seeking Alpha
Mon, 05/20/13 - 11:23 am
pSivida
GTx
Iluvien
enobosarm
GTx And Trius Therapeutics: 2 Top Biotech Buys For 2013
Seeking Alpha
Thu, 04/18/13 - 08:05 am
GTx
Trius Therapeutics
enobosarm
TR-701
FDA designates GTx's enobosarm as Fast Track development program
Yahoo/Fly on the Wall
Tue, 01/8/13 - 10:38 am
FDA
GTx
enobosarm
fast track
non-small cell lung cancer
6 Biotech Stocks That Analysts Give The Green Light
Seeking Alpha
Fri, 07/27/12 - 12:05 pm
GTx
Illumina
InterMune
QLT
Seattle Genetics
Vivus
GTx announces presentation of Phase IIb enoborsarm study results
The Fly on the Wall
Mon, 06/25/12 - 03:24 pm
GTx
enoborsarm
Pages
1
2
3
next ›
last »